Company family · HQ CZ
Zentiva: medicine shortages
private (GTCR)
As of 2 Nov 2026, 340 Zentiva products have a reported shortage across 9 countries, covering 159 medicines.
Products short340rank #7 of 464
Medicines159active ingredients
Countries9/16
New in 90 days65-9 vs market pace
Typical duration17 monthsmedian so far
Manufacturing76%demand-driven 19%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Duloxetine | 10 | 30 Sep 2024 | Manufacturing problem | 12/16 | |
| Telmisartan and Diuretics | 9 | 26 Jun 2023 | Manufacturing problem | 4/16 | |
| Amlodipine | 7 | 16 Jun 2023 | Manufacturing problem | 8/16 | |
| Fingolimod | 7 | 5 Jun 2026 | Quality problem or recall | 9/16 | |
| Ibuprofen | 7 | 9 May 2022 | Manufacturing problem | 8/16 | |
| Paliperidone | 7 | 31 Jul 2026 | Manufacturing problem | 11/16 | |
| Pregabalin | 7 | 1 May 2021 | Manufacturing problem | 11/16 | |
| Lacosamide | 6 | 7 Aug 2023 | Manufacturing problem | 6/16 | |
| Metoprolol | 6 | 13 Mar 2026 | Manufacturing problem | 9/16 | |
| Omeprazole | 6 | 31 Oct 2023 | Manufacturing problem | 8/16 | |
| Ramipril and Amlodipine | 6 | 31 Dec 2023 | Manufacturing problem | 3/16 | |
| Tadalafil | 6 | 30 Jun 2020 | Manufacturing problem | 10/16 | |
| Venlafaxine | 6 | 31 Jul 2023 | Manufacturing problem | 10/16 | |
| Apremilast | 5 | 5 Jun 2026 | Manufacturing problem | 5/16 | |
| Atomoxetine | 5 | 20 Jul 2026 | Manufacturing problem | 11/16 | |
| Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | 5 | 11 Oct 2024 | Increased demand | 3/16 | |
| Colecalciferol | 4 | 17 Oct 2022 | Manufacturing problem | 8/16 | |
| Rivastigmine | 4 | 15 Oct 2021 | Increased demand | 6/16 | |
| Rosuvastatin and Amlodipine | 4 | 31 May 2024 | Manufacturing problem | 1/16 | |
| Valsartan | 4 | 3 Jul 2018 | Manufacturing problem | 7/16 | |
| Aripiprazole | 3 | 15 Jun 2022 | Manufacturing problem | 9/16 | |
| Deferasirox | 3 | 21 Dec 2022 | Manufacturing problem | 8/16 | |
| Diltiazem | 3 | 29 Feb 2024 | Increased demand | 7/16 | |
| Diosmin, Combinations | 3 | 15 Dec 2025 | Manufacturing problem | 1/16 | |
| Fentanyl | 3 | 17 Jul 2023 | Manufacturing problem | 9/16 | |
| Gabapentin | 3 | 22 Aug 2022 | Manufacturing problem | 9/16 | |
| Iloprost | 3 | 16 Sep 2024 | Manufacturing problem | 1/16 | |
| Irbesartan and Diuretics | 3 | 26 Sep 2022 | Manufacturing problem | 4/16 | |
| Lorazepam | 3 | 30 Apr 2025 | Manufacturing problem | 5/16 | |
| Losartan and Diuretics | 3 | 1 Sep 2021 | Manufacturing problem | 4/16 | |
| Methylphenidate | 3 | 15 Sep 2026 | Not stated | 9/16 | |
| Mometasone | 3 | 15 Aug 2024 | Manufacturing problem | 5/16 | |
| Olmesartan Medoxomil | 3 | 30 Jul 2022 | Manufacturing problem | 5/16 | |
| Olmesartan Medoxomil and Amlodipine | 3 | 21 Aug 2023 | Manufacturing problem | 4/16 | |
| Olmesartan Medoxomil and Diuretics | 3 | 31 Aug 2023 | Manufacturing problem | 4/16 | |
| Paracetamol | 3 | 30 Sep 2024 | Manufacturing problem | 10/16 | |
| Rosuvastatin | 3 | 30 Apr 2023 | Manufacturing problem | 12/16 | |
| Simvastatin and Ezetimibe | 3 | 28 Feb 2021 | Manufacturing problem | 8/16 | |
| Sunitinib | 3 | 31 Oct 2022 | Increased demand | 5/16 | |
| Acetylsalicylic Acid, Combinations excl. Psycholeptics | 2 | 30 Apr 2026 | Manufacturing problem | 3/16 | |
| Aciclovir | 2 | 30 Jun 2026 | Increased demand | 6/16 | |
| Amoxicillin and Beta-Lactamase Inhibitor | 2 | 11 Mar 2022 | Manufacturing problem | 7/16 | |
| Ascorbic Acid (Vit C) | 2 | 26 Oct 2026 | Manufacturing problem | 1/16 | |
| Atorvastatin | 2 | 5 Oct 2026 | Manufacturing problem | 11/16 | |
| Bisoprolol | 2 | 11 Nov 2024 | Manufacturing problem | 6/16 | |
| Candesartan and Diuretics | 2 | 12 Dec 2022 | Manufacturing problem | 5/16 | |
| Citalopram | 2 | 31 Jan 2023 | Manufacturing problem | 5/16 | |
| Desmopressin | 2 | 31 Oct 2024 | Increased demand | 8/16 | |
| Doxazosin | 2 | 30 Aug 2025 | Manufacturing problem | 5/16 | |
| Enalapril and lercanidipine | 2 | 30 Jun 2025 | Manufacturing problem | 2/16 | |
| Escitalopram | 2 | 30 Dec 2022 | Manufacturing problem | 10/16 | |
| Etoricoxib | 2 | 24 Dec 2021 | Manufacturing problem | 7/16 | |
| Felodipine | 2 | 1 Oct 2022 | Manufacturing problem | 5/16 | |
| Formoterol and Beclometasone | 2 | 15 Apr 2026 | Increased demand | 1/16 | |
| Ivabradine | 2 | 31 Mar 2025 | Increased demand | 9/16 | |
| Ketoprofen | 2 | 1 Feb 2022 | Manufacturing problem | 4/16 | |
| Levetiracetam | 2 | 30 May 2023 | Manufacturing problem | 9/16 | |
| Meloxicam | 2 | 15 Jan 2025 | Commercial decision or withdrawal | 3/16 | |
| Metformin and Vildagliptin | 2 | 15 Dec 2023 | Manufacturing problem | 3/16 | |
| Olanzapine | 2 | 15 Jul 2022 | Increased demand | 13/16 | |
| Pantoprazole | 2 | 14 Oct 2024 | Manufacturing problem | 9/16 | |
| Perindopril and Amlodipine | 2 | 31 Aug 2026 | Increased demand | 5/16 | |
| Pravastatin | 2 | 28 Feb 2026 | Manufacturing problem | 6/16 | |
| Quetiapine | 2 | 6 Jul 2021 | Manufacturing problem | 12/16 | |
| Rabeprazole | 2 | 31 Aug 2026 | Manufacturing problem | 5/16 | |
| Ramipril and Diuretics | 2 | 1 Jan 2025 | Increased demand | 4/16 | |
| Rizatriptan | 2 | 16 Jun 2025 | Manufacturing problem | 6/16 | |
| Sertraline | 2 | 5 Aug 2022 | Increased demand | 11/16 | |
| Sildenafil | 2 | 31 Jul 2026 | Increased demand | 10/16 | |
| Simvastatin | 2 | 15 Nov 2021 | Manufacturing problem | 9/16 | |
| Sorafenib | 2 | 31 Jan 2023 | Manufacturing problem | 6/16 | |
| Sumatriptan | 2 | 30 Nov 2024 | Manufacturing problem | 13/16 | |
| Telmisartan | 2 | 12 Dec 2022 | Manufacturing problem | 6/16 | |
| Telmisartan and Amlodipine | 2 | 9 Nov 2026 | Manufacturing problem | 3/16 | |
| Terazosin | 2 | 30 Nov 2024 | Commercial decision or withdrawal | 4/16 | |
| Ticagrelor | 2 | 5 Jun 2026 | Manufacturing problem | 2/16 | |
| Valsartan and Amlodipine | 2 | 31 May 2024 | Manufacturing problem | 5/16 | |
| Acetylsalicylic Acid | 1 | 31 Jan 2024 | Manufacturing problem | 4/16 | |
| Alfacalcidol | 1 | 7 Aug 2026 | Increased demand | 3/16 | |
| Alfuzosin | 1 | 15 Jul 2022 | Manufacturing problem | 1/16 | |
| Almotriptan | 1 | 16 Jun 2025 | Manufacturing problem | 2/16 | |
| Alprazolam | 1 | 10 Sep 2025 | Manufacturing problem | 6/16 | |
| Ambrisentan | 1 | 15 Oct 2026 | Manufacturing problem | 6/16 | |
| Amiodarone | 1 | 10 Dec 2025 | Manufacturing problem | 5/16 | |
| Anastrozole | 1 | 31 May 2023 | Manufacturing problem | 5/16 | |
| Aprepitant | 1 | 1 Oct 2025 | Manufacturing problem | 12/16 | |
| Atorvastatin and Ezetimibe | 1 | 30 Sep 2024 | Increased demand | 6/16 | |
| Betamethasone | 1 | 31 May 2025 | Commercial decision or withdrawal | 7/16 | |
| Betamethasone and Antibiotics | 1 | 21 Jul 2025 | Manufacturing problem | 2/16 | |
| Bosutinib | 1 | 14 Feb 2025 | Increased demand | 2/16 | |
| Bromazepam | 1 | 12 Dec 2022 | Manufacturing problem | 4/16 | |
| Bupropion | 1 | 7 Oct 2024 | Increased demand | 7/16 | |
| Calcium Levofolinate | 1 | 23 Jul 2026 | Not stated | 2/16 | |
| Candesartan | 1 | 31 May 2023 | Manufacturing problem | 10/16 | |
| Candesartan and Amlodipine | 1 | 27 Nov 2026 | Manufacturing problem | 3/16 | |
| Capecitabine | 1 | 26 May 2023 | Increased demand | 6/16 | |
| Carmustine | 1 | 25 Sep 2025 | Not stated | 3/16 | |
| Carvedilol | 1 | 31 Mar 2026 | Manufacturing problem | 8/16 | |
| Cetirizine | 1 | 14 Aug 2026 | Increased demand | 4/16 | |
| Ciclopirox | 1 | 4 Dec 2026 | Manufacturing problem | 3/16 | |
| Clarithromycin | 1 | 21 Mar 2022 | Manufacturing problem | 5/16 | |
| Codeine and Paracetamol | 1 | 20 Oct 2026 | Manufacturing problem | 4/16 | |
| Dasatinib | 1 | 13 Nov 2023 | Manufacturing problem | 6/16 | |
| Desloratadine | 1 | 31 Jan 2025 | Commercial decision or withdrawal | 7/16 | |
| Diazepam | 1 | 31 Aug 2025 | Manufacturing problem | 7/16 | |
| Diosmin | 1 | 30 Sep 2026 | Manufacturing problem | 3/16 | |
| Drospirenone and Ethinylestradiol | 1 | 21 Aug 2023 | Manufacturing problem | 5/16 | |
| Dutasteride | 1 | 31 Dec 2023 | Manufacturing problem | 4/16 | |
| Emtricitabine, Tenofovir Disoproxil and Efavirenz | 1 | 5 Aug 2022 | Increased demand | 4/16 | |
| Eribulin | 1 | 30 Jun 2026 | Increased demand | 2/16 | |
| Esomeprazole | 1 | 15 May 2025 | Manufacturing problem | 9/16 | |
| Exemestane | 1 | 15 Aug 2026 | Increased demand | 3/16 | |
| Ezetimibe | 1 | 30 Apr 2026 | Increased demand | 9/16 | |
| Fenofibrate | 1 | 17 Jan 2022 | Manufacturing problem | 2/16 | |
| Fluconazole | 1 | 21 Jul 2025 | Manufacturing problem | 12/16 | |
| Folic Acid | 1 | 9 Nov 2026 | Manufacturing problem | 3/16 | |
| Fulvestrant | 1 | 30 Aug 2025 | Manufacturing problem | 5/16 | |
| Gentamicin | 1 | 30 Nov 2024 | Manufacturing problem | 1/16 | |
| Gliquidone | 1 | 17 Jul 2026 | Regulatory or licensing | 1/16 | |
| Goserelin | 1 | 16 Oct 2026 | Manufacturing problem | 1/16 | |
| Guaifenesin | 1 | 10 Nov 2026 | Manufacturing problem | 1/16 | |
| Ibandronic Acid | 1 | 30 Nov 2022 | Manufacturing problem | 4/16 | |
| Icatibant | 1 | 20 Apr 2026 | Not stated | 8/16 | |
| Isoniazid | 1 | 29 Oct 2026 | Manufacturing problem | 4/16 | |
| Itopride | 1 | 4 Dec 2026 | Manufacturing problem | 2/16 | |
| Lactulose | 1 | 27 Mar 2023 | Manufacturing problem | 3/16 | |
| Lansoprazole | 1 | 31 Jul 2026 | Manufacturing problem | 8/16 | |
| Latanoprost | 1 | 30 Nov 2022 | Manufacturing problem | 4/16 | |
| Leflunomide | 1 | 27 Oct 2023 | Manufacturing problem | 3/16 | |
| Lenalidomide | 1 | 16 Sep 2026 | Manufacturing problem | 10/16 | |
| Lofepramine | 1 | 1 Aug 2023 | Manufacturing problem | 1/16 | |
| Lormetazepam | 1 | 14 Nov 2022 | Manufacturing problem | 1/16 | |
| Manidipine | 1 | 21 Mar 2022 | Manufacturing problem | 2/16 | |
| Melatonin | 1 | 29 May 2026 | Increased demand | 1/16 | |
| Melphalan | 1 | 25 Aug 2026 | Not stated | 4/16 | |
| Metformin | 1 | 31 Mar 2025 | Manufacturing problem | 8/16 | |
| Mirtazapine | 1 | 30 Nov 2022 | Manufacturing problem | 10/16 | |
| Paracetamol, Combinations excl. Psycholeptics | 1 | 24 Jan 2023 | Manufacturing problem | 5/16 | |
| Paroxetine | 1 | 24 Oct 2022 | Manufacturing problem | 8/16 | |
| Pazopanib | 1 | 31 Aug 2026 | Manufacturing problem | 4/16 | |
| Pentoxifylline | 1 | 17 Aug 2026 | Manufacturing problem | 5/16 | |
| Perindopril | 1 | 31 Aug 2026 | Manufacturing problem | 5/16 | |
| Perindopril and Diuretics | 1 | 31 Jul 2026 | Increased demand | 6/16 | |
| Pirfenidone | 1 | 15 Feb 2024 | Manufacturing problem | 6/16 | |
| Posaconazole | 1 | 31 Jan 2024 | Manufacturing problem | 6/16 | |
| Potassium Chloride | 1 | 23 Jun 2025 | Manufacturing problem | 4/16 | |
| Pramipexole | 1 | 30 Jun 2022 | Manufacturing problem | 6/16 | |
| Risedronic Acid | 1 | 14 Feb 2025 | Increased demand | 3/16 | |
| Risperidone | 1 | 20 Nov 2026 | Manufacturing problem | 13/16 | |
| Rivaroxaban | 1 | 27 Dec 2024 | Manufacturing problem | 13/16 | |
| Silodosin | 1 | 29 Mar 2024 | Manufacturing problem | 4/16 | |
| Sitagliptin | 1 | 30 Oct 2026 | Increased demand | 8/16 | |
| Tamsulosin | 1 | 18 Mar 2024 | Increased demand | 6/16 | |
| Timolol, Combinations | 1 | 17 Jul 2023 | Increased demand | 9/16 | |
| Tranexamic Acid | 1 | 9 Aug 2026 | Not stated | 10/16 | |
| Travoprost | 1 | 15 Dec 2023 | Manufacturing problem | 7/16 | |
| Triamcinolone and Antiseptics | 1 | 15 Jun 2026 | Manufacturing problem | 1/16 | |
| Valsartan and Diuretics | 1 | 2 Oct 2026 | Manufacturing problem | 7/16 | |
| Various | 1 | 31 Oct 2025 | Manufacturing problem | 1/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.